Compass Therapeutics Inc (CMPX) Financials

$2.43

$0.06 (2.32%)

As on 04-Sep-2026 13:35EDT

Market cap

$432 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	0.85	--	--	--
Cost of Revenue	0.74	1.47	--	1.89	1.90	1.62
Gross Profit	-0.74	-1.47	0.85	-1.89	-1.90	-1.62
Operating Expenses	80.35	71.37	57.48	50.36	41.66	81.88
Operating Profit (EBIT)	-81.09	-72.84	-56.63	-50.36	-41.66	-81.88
Other Income	--	--	--	--	2.43	-0.30
Profit before Tax	-73.45	-66.49	-49.38	-42.49	-39.23	-82.18
Provision for Tax	--	--	--	--	-2.43	0.37
Profit after Tax (Net Income)	-73.45	-66.49	-49.38	-42.49	-39.23	-82.18
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-39.23	-82.18

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	166.05	196.79	125.23	148.54	181.64	140.08
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	8.00	8.83	6.30	0.54	1.84	3.05
Current Liabilities	16.13	13.97	8.87	7.80	16.17	10.63
Total Liabilities	206.30	219.59	140.40	156.88	199.65	153.76

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	9.28	9.77	7.65	2.99	4.85	6.65
Current Assets	180.89	209.82	132.75	153.88	194.79	147.11
Total Assets	206.30	219.59	140.40	156.88	199.65	153.76
Total Debt*	9.63	9.83	6.63	1.73	2.94	4.04
Net Current Assets	164.76	195.85	123.88	146.08	178.62	136.47

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-49.14	-44.86	-40.62	-34.13	-19.67
Cash Flow from Investing Activities	--	-93.31	46.77	26.97	-151.20	-1.77
Cash from Financing Activities	--	129.61	17.34	2.94	75.76	118.61
Net Cash Inflow / Outflow	--	--	--	--	-109.57	97.18

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.42	-0.36	-0.36	-0.33	-0.37	-1.58
Cash EPS ($)	--	-0.35	-0.35	-0.32	-0.35	-1.55
Adjusted Book Value ($)	--	1.06	0.92	1.16	1.73	2.70
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.27	-0.33	-0.32	-0.32	-0.38
Free Cash Flow per Share ($)	--	-0.27	-0.33	-0.32	-0.33	-0.41

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-39.29	-35.00	-25.38	-23.87	-84.99
ROE (%)	-40.48	-41.29	-36.07	-25.74	-24.38	-91.30
ROA (%)	-43.61	-36.94	-33.22	-23.84	-22.20	-79.92
EBIT Margin (%)	--	--	-5,808.82	--	--	--
Net Margin (%)	--	--	-5,808.82	--	-1,614.20	27,485.28
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	-1.00	--	--	--	--
EBIT Growth (%)	-18.41	-34.66	-16.19	-15.27	54.94	-194.16
Net Profit Growth (%)	-18.41	-34.66	-16.19	-8.33	52.27	-178.58
EPS Growth (%)	6.49	0.00	-0.09	0.11	0.76	-2.28
Book Value Growth (%)	31.88	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-14.93	-4.01	-4.69	-13.49	-2.00
Price / Book Value	2.74	5.04	1.58	1.34	2.91	1.17
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-8.92	-12.21	-1.64	-1.19	-9.88	-0.30
Close Price ($)	2.19	5.37	1.45	1.56	5.03	3.17
High Price ($)	6.88	5.86	2.34	5.55	5.65	11.00
Low Price ($)	1.61	1.33	0.77	1.35	1.25	2.01
Market Cap ($ Cr)	432.21	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.05	0.05	0.01	0.02	0.03
Short term debt to equity ratio	0.01	0.01	0.00	0.01	0.01	0.01
Current Ratio	11.22	15.02	14.96	19.73	12.05	13.84
Quick Ratio	11.22	--	--	--	--	--
Interest Coverage	--	--	--	--	-15.62	-221.11

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	0.01	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	475.67	--	722.00	407.55	216.81
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.